Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 14,201 shares at $28.01 ($398K) on 2019-08-21, disclosed to the SEC on 2019-08-23.
Open-market sale of $398k HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| HZNP | SELL | 2022-03-25 | $5.7M | — | Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |